Immunotherapy of Rheumatoid Arthritis: A Review

Abstract

Background and Aims-Immunotherapy is a revolutionary treatment approach for rheumatoid arthritis. However, based on our knowledge, the disease is not well studied. Understanding the pathophysiology, possible diagnosis, and management interventions for rheumatoid arthritis is crucial for improving the quality of life for individuals with the disease. This study was conducted based on the PRISMA guidelines for review. Our data showed that immunotherapy has demon- strated significant potential in the management of rheumatoid arthritis by specifically targeting dysregulated immune responses implicated in the disease pathogenesis. TNF-α inhibitors, IL-6 receptor antagonists, B-cell depletion therapy, and JAK inhibitors have all shown efficacy in reduc- ing inflammation and improving clinical outcomes in rheumatoid -arthritis patients. In addition, by targeting the key immune pathways, immunotherapy demonstrated a substantial impact in reducing the disease activity and slowing the progression of joint damage. Consequently, immu- notherapy is a valuable therapeutic option for rheumatoid arthritis patients who do not respond adequately to the traditional treatment modalities. As our understanding of the immunological processes in rheumatoid arthritis deepens, further advances in immunotherapy are expected, providing hope for more personalized and effective approaches to managing the chronic autoim- mune disease.